The Westminster lensArchive · §02 Speeches · 816 contributions

Speeches by Coleman.

Every Hansard contribution by Ben Coleman this parliament, most recent first. Back to the MP page for the headline figures and analysed positions.

Showing 121140 of 816 contributions · most-recent first

← PreviousPage 7 of 41Next →
DateDebate & contributionWords
5 Mar 2026 Palliative Care

Can the Minister confirm that the MSF will include targeted support for children who require palliative care?

healthsocial-care
17
5 Mar 2026 Palliative Care

I am very grateful to my hon. Friend the Member for York Central (Rachael Maskell) for calling this vital debate. As the right hon. Member for New Forest East (Sir Julian Lewis) did, I will talk about children, and I would like to start with Amy. Amy had Cockayne syndrome, which is a severe, fatal, multi-organ genetic

healthsocial-care
1,120
2 Mar 2026School SEND Provision

18. What steps she is taking to improve SEND provision in schools.

educationsocial-care
12
2 Mar 2026School SEND Provision

This plan is to be welcomed. It rightly recognises that families of children with SEND are absolutely exhausted from having to fight and battle for the support they need. I therefore strongly welcome the commitment to end that and to give over 1 million children, for the first time, legally enforceable rights through t

educationsocial-care
130
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

But do you not think that—ironically, seeing as people do not seem to keep the weight off for an extended period at the moment—the drugs over the long term could increase obesity in the general population by reducing people’s motivation to tackle the root causes?

45
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

I understand that, and we have discussed that quite extensively. You say that prevention should always be the first line of defence. Your share price is rocketing. I wish we all had shares in Lilly; we would all be a lot richer. Do you not have a financial interest against prevention? I am not talking about morals; I a

104
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

There are all sorts of other conditions that people take medication for. It is a bit boring, but—

18
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

I must stop you there. What makes you say that nobody wants to be on medication for life? People who have high blood pressure take high blood pressure pills for life.

31
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Can I ask a couple of questions about other aspects? We have an obesogenic environment, which I know Professor Jebb has done a lot of work on. The Committee has talked a lot about trying to reduce the obesogenic environment through healthy food and so on. Does getting the easy pharma jab not reduce the urgency of tackl

92
25 Feb 2026 UK-German Relations

Not for the first time, my hon. Friend puts it much better than I could. Cyber-security is an absolutely key pillar of the Trinity House agreement, and AI, quantum and semiconductor investment should be things that Germany and Britain work on together, side by side, to defend our joint security and also contribute to t

defenceeconomy-jobsculture-community
479
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

At this stage, do you think that NICE should look again at the assessment it has already made?

18
25 Feb 2026 UK-German Relations

It is a pleasure to serve under your chairship, Mr Twigg. I have been passionate about strengthening ties between the UK and Germany for most of my adult life, ever since I spent two years living in West Berlin in the mid-1980s—vor der Wende—before the wall came down. I lived in Kreuzberg, a neighbourhood that at that

defenceeconomy-jobsculture-community
595
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Thank you very much. Dr Coelho, do you have any views on this?

13
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

When you say that the assessment has been robust, that suggests that it is using the best available data and a whole range of other factors. However, the recentness of the analysis is important. If things are changing all the time, how robust is the data?

46
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

It would be good to get the views of Dr Pegg and Dr Coelho as well.

16
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

When you say “potentially”, that suggests that you see upsides and downsides. What are the downsides?

16
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

That is very helpful. Given the speed at which these drugs are being adopted and given that we are learning all the time about what they are doing, what impact they are having and what impact they are not having over the long term, is there a case for NICE to assess and reassess the drugs and the advice it gives to Gov

85
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

When you say “potentially”—?

4
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Would you say that it should be looking at reassessing the work that it has already done, because there is now more data out there?

25
25 Feb 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Thank you all very much for coming. I would like to understand weight regain a little better. If people cannot actually keep the weight off, it is just a licence to print money for pharmaceutical companies. Professor Jebb, the Committee had some evidence from NICE in August that suggested that weight regain occurs afte

101
← PreviousPage 7 of 41 · click a debate to open the transcript with this MP’s speeches highlightedNext →
Sources
SourceHansard · official report
MethodEach row is one contribution (intervention or speech). Word count from the official text.